PortfoliosLab logoPortfoliosLab logo
CLS.TO vs. HIMS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CLS.TO vs. HIMS - Performance Comparison

The chart below illustrates the hypothetical performance of a CA$10,000 investment in Celestica Inc. (CLS.TO) and Hims & Hers Health, Inc. (HIMS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

CLS.TO is traded in CAD, while HIMS is traded in USD. To make them comparable, the HIMS values have been converted to CAD using the latest available exchange rates.

Returns By Period

In the year-to-date period, CLS.TO achieves a 32.58% return, which is significantly higher than HIMS's -14.80% return.


CLS.TO

1D
3.80%
1M
4.71%
YTD
32.58%
6M
13.91%
1Y
225.20%
3Y*
213.80%
5Y*
120.83%
10Y*
44.44%

HIMS

1D
4.03%
1M
-1.90%
YTD
-14.80%
6M
-30.00%
1Y
-50.79%
3Y*
46.60%
5Y*
18.39%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

CLS.TO vs. HIMS - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
CLS.TO
Celestica Inc.
32.58%206.05%241.82%154.33%8.23%37.29%-4.64%11.03%
HIMS
Hims & Hers Health, Inc.
-14.80%28.15%194.69%35.54%4.06%-55.16%43.98%0.07%

Correlation

The correlation between CLS.TO and HIMS is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.26

Correlation (3Y)
Calculated over the trailing 3-year period

0.30

Correlation (5Y)
Calculated over the trailing 5-year period

0.28

Correlation (All Time)
Calculated using the full available price history since Sep 13, 2019

0.23

Fundamentals

Market Cap

CLS.TO:

CA$62.28B

HIMS:

$6.20B

EPS

CLS.TO:

CA$8.28

HIMS:

-$0.05

PS Ratio

CLS.TO:

4.52

HIMS:

2.81

PB Ratio

CLS.TO:

29.68

HIMS:

13.91

Total Revenue (TTM)

CLS.TO:

CA$13.81B

HIMS:

$2.37B

Gross Profit (TTM)

CLS.TO:

CA$1.60B

HIMS:

$1.70B

EBITDA (TTM)

CLS.TO:

CA$1.36B

HIMS:

$16.04M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CLS.TO vs. HIMS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLS.TO
CLS.TO Risk / Return Rank: 9393
Overall Rank
CLS.TO Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
CLS.TO Sortino Ratio Rank: 8989
Sortino Ratio Rank
CLS.TO Omega Ratio Rank: 8989
Omega Ratio Rank
CLS.TO Calmar Ratio Rank: 9696
Calmar Ratio Rank
CLS.TO Martin Ratio Rank: 9595
Martin Ratio Rank

HIMS
HIMS Risk / Return Rank: 2020
Overall Rank
HIMS Sharpe Ratio Rank: 1818
Sharpe Ratio Rank
HIMS Sortino Ratio Rank: 2222
Sortino Ratio Rank
HIMS Omega Ratio Rank: 2323
Omega Ratio Rank
HIMS Calmar Ratio Rank: 1818
Calmar Ratio Rank
HIMS Martin Ratio Rank: 1919
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CLS.TO vs. HIMS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Celestica Inc. (CLS.TO) and Hims & Hers Health, Inc. (HIMS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CLS.TOHIMSDifference
Sharpe ratioReturn per unit of total volatility

+3.71

Sortino ratioReturn per unit of downside risk

+3.38

Omega ratioGain probability vs. loss probability

1.41

0.95

+0.45

Calmar ratioReturn relative to maximum drawdown

7.15

-0.65

+7.80

Martin ratioReturn relative to average drawdown

17.88

-1.07

+18.95

CLS.TO vs. HIMS - Sharpe Ratio Comparison

The current CLS.TO Sharpe Ratio is 3.17, which is higher than the HIMS Sharpe Ratio of -0.53. The chart below compares the historical Sharpe Ratios of CLS.TO and HIMS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CLS.TOHIMSDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

3.17

-0.53

+3.71

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

2.16

0.22

+1.93

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.92

Sharpe Ratio (All Time)

Calculated using the full available price history

0.47

0.22

+0.25

Drawdowns

CLS.TO vs. HIMS - Drawdown Comparison

The maximum CLS.TO drawdown since its inception was -79.32%, smaller than the maximum HIMS drawdown of -87.01%. Use the drawdown chart below to compare losses from any high point for CLS.TO and HIMS.


Loading charts...

Drawdown Indicators


CLS.TOHIMSDifference

Max Drawdown

Largest peak-to-trough decline

-79.32%

-87.01%

+7.69%

Max Drawdown (1Y)

Largest decline over 1 year

-31.71%

-78.30%

+46.59%

Max Drawdown (3Y)

Largest decline over 3 years

-54.25%

-79.64%

+25.39%

Max Drawdown (5Y)

Largest decline over 5 years

-54.25%

-79.64%

+25.39%

Max Drawdown (10Y)

Largest decline over 10 years

-79.32%

Current Drawdown

Current decline from peak

-17.55%

-61.16%

+43.61%

Average Drawdown

Average peak-to-trough decline

-28.86%

-43.06%

+14.20%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.66%

47.57%

-34.91%

Volatility

CLS.TO vs. HIMS - Volatility Comparison

Celestica Inc. (CLS.TO) and Hims & Hers Health, Inc. (HIMS) have volatilities of 26.92% and 26.26%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CLS.TOHIMSDifference

Volatility (1M)

Calculated over the trailing 1-month period

26.92%

26.26%

+0.66%

Volatility (6M)

Calculated over the trailing 6-month period

54.95%

66.59%

-11.64%

Volatility (1Y)

Calculated over the trailing 1-year period

71.57%

96.12%

-24.55%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

56.52%

83.63%

-27.11%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

48.79%

77.54%

-28.75%

Dividends

CLS.TO vs. HIMS - Dividend Comparison

Neither CLS.TO nor HIMS has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

CLS.TO vs. HIMS - Financials Comparison

This section allows you to compare key financial metrics between Celestica Inc. and Hims & Hers Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B20222023202420252026
4.05B
608.10M
(CLS.TO) Total Revenue
(HIMS) Total Revenue
Please note, different currencies. CLS.TO values in CAD, HIMS values in USD

CLS.TO vs. HIMS - Profitability Comparison

The chart below illustrates the profitability comparison between Celestica Inc. and Hims & Hers Health, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%20222023202420252026
10.8%
65.3%
Portfolio components
CLS.TO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Celestica Inc. reported a gross profit of 437.20M and revenue of 4.05B. Therefore, the gross margin over that period was 10.8%.

HIMS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a gross profit of 396.79M and revenue of 608.10M. Therefore, the gross margin over that period was 65.3%.

CLS.TO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Celestica Inc. reported an operating income of 267.70M and revenue of 4.05B, resulting in an operating margin of 6.6%.

HIMS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported an operating income of -78.32M and revenue of 608.10M, resulting in an operating margin of -12.9%.

CLS.TO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Celestica Inc. reported a net income of 212.30M and revenue of 4.05B, resulting in a net margin of 5.3%.

HIMS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a net income of -92.12M and revenue of 608.10M, resulting in a net margin of -15.2%.


Frequently Asked Questions


CLS.TO and HIMS have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for CLS.TO and HIMS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer